Vaccines Market By Technology (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines), By Indication (Dengue, DTP, Hepatitis, HPV, Influenza, Meningococcal, MMR, Pneumococcal, Polio, Rotavirus, Varicella) By Type(Monovalent, Multivalent) By Route of Administration(Intramuscular, Subcutaneous, Oral, Others) By Type of Patient(Children, Adult) - Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

Table Of Content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Vaccine
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Vaccine Market By Technology
     1.2.2.1. Global Vaccine Market Revenue and Growth Rate Comparison By Technology (2015-2026)
     1.2.2.2. Global Vaccine Market Revenue Share By Technology in 2017
     1.2.2.3. Conjugate Vaccines
     1.2.2.4. Inactivated Vaccines
     1.2.2.5. Live Attenuated Vaccines
     1.2.2.6. Toxoid Vaccines
     1.2.2.7. Recombinant Vaccines
   1.2.3. Vaccine Market By Indication
     1.2.3.1. Global Vaccine Market Revenue and Growth Rate Comparison By Indication (2015-2026)
     1.2.3.2. Global Vaccine Market Revenue Share By Indication in 2017
     1.2.3.3. Dengue
     1.2.3.4. DTP
     1.2.3.5. Hepatitis
     1.2.3.6. HPV
     1.2.3.7. Influenza
     1.2.3.8. Meningococcal
     1.2.3.9. MMR
     1.2.3.10. Pneumococcal
     1.2.3.11. Polio
     1.2.3.12. Rotavirus
     1.2.3.13. Varicella
   1.2.4. Vaccine Market By Type
     1.2.4.1. Global Vaccine Market Revenue and Growth Rate Comparison By Type (2015-2026)
     1.2.4.2. Global Vaccine Market Revenue Share By Type in 2017
     1.2.4.3. Monovalent
     1.2.4.4. Multivalent
   1.2.5. Vaccine Market By Route of Administration
     1.2.5.1. Global Vaccine Market Revenue and Growth Rate Comparison By Route of Administration (2015-2026)
     1.2.5.2. Global Vaccine Market Revenue Share By Route of Administration in 2017
     1.2.5.3. Intramuscular
     1.2.5.4. Subcutaneous
     1.2.5.5. Oral
     1.2.5.6. Others
   1.2.6. Vaccine Market By Type of Patient
     1.2.6.1. Global Vaccine Market Revenue and Growth Rate Comparison By Type of Patient (2015-2026)
     1.2.6.2. Global Vaccine Market Revenue Share By Type of Patient in 2017
     1.2.6.3. Children
     1.2.6.4. Adult
   1.2.7. Vaccine Market By Geography
     1.2.7.1. Global Vaccine Market Revenue and Growth Rate Comparison by Geography (2015-2026)
     1.2.7.2. North America Vaccine Market Revenue and Growth Rate (2015-2026)
     1.2.7.3. Europe Vaccine Market Revenue and Growth Rate (2015-2026)
     1.2.7.4. Asia-Pacific Vaccine Market Revenue and Growth Rate (2015-2026)
     1.2.7.5. Latin America Vaccine Market Revenue and Growth Rate (2015-2026)
     1.2.7.6. Middle East and Africa (MEA) Vaccine Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Vaccine Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Vaccine Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Vaccine Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Vaccine Major Manufacturers in 2017

CHAPTER 4. Vaccine Market By Technology
4.1. Global Vaccine Revenue By Technology
4.2. Conjugate Vaccines
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Inactivated Vaccines
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Live Attenuated Vaccines
   4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Toxoid Vaccines
   4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Recombinant Vaccines
   4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Vaccine Market By Indication
5.1. Global Vaccine Revenue By Indication
5.2. Dengue
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. DTP
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Hepatitis
   5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. HPV
   5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Influenza
   5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Meningococcal
   5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. MMR
   5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.9. Pneumococcal
   5.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.10. Polio
   5.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.11. Rotavirus
   5.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.12. Varicella
   5.12.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.12.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. Vaccine Market By Type
6.1. Global Vaccine Revenue By Type
6.2. Monovalent
   6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Multivalent
   6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. Vaccine Market By Route of Administration
7.1. Global Vaccine Revenue By Route of Administration
7.2. Intramuscular
   7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Subcutaneous
   7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Oral
   7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Others
   7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. Vaccine Market By Type of Patient
8.1. Global Vaccine Revenue By Type of Patient
8.2. Children
   8.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   8.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.3. Adult
   8.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 9. North America Vaccine Market By Country
9.1. North America Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. North America Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. U.S.
   9.3.1. U.S. Vaccine Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
9.4. Canada
   9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 10. Europe Vaccine Market By Country
10.1. Europe Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Europe Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. UK
   10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.4. Germany
   10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.5. France
   10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.6. Spain
   10.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.6.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.7. Rest of Europe
   10.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.7.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 11. Asia-Pacific Vaccine Market By Country
11.1. Asia-Pacific Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Asia-Pacific Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. China
   11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   11.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.4. Japan
   11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   11.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.5. India
   11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   11.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.6. Australia
   11.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   11.6.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.7. South Korea
   11.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   11.7.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.8. Rest of Asia-Pacific
   11.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   11.8.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 12. Latin America Vaccine Market By Country
12.1. Latin America Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Latin America Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Brazil
   12.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   12.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
12.4. Mexico
   12.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   12.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
12.5. Rest of Latin America
   12.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   12.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 13. MIDDLE EAST & AFRICA VACCINE MARKET BY COUNTRY
13.1. Middle East & Africa Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Middle East & Africa Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. GCC
   13.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   13.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
13.4. South Africa
   13.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   13.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
13.5. Rest of Middle East & Africa
   13.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   13.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 14. COMPANY PROFILE
14.1. Astellas Pharma Inc.
   14.1.1. Company Snapshot
   14.1.2. Overview
   14.1.3. Financial Overview
   14.1.4. Product Portfolio
   14.1.5. Key Developments
   14.1.6. Strategies
14.2. Bavarian Nordic
   14.2.1. Company Snapshot
   14.2.2. Overview
   14.2.3. Financial Overview
   14.2.4. Product Portfolio
   14.2.5. Key Developments
   14.2.6. Strategies
14.3. CSL Limited
   14.3.1. Company Snapshot
   14.3.2. Overview
   14.3.3. Financial Overview
   14.3.4. Product Portfolio
   14.3.5. Key Developments
   14.3.6. Strategies
14.4. Daiichi Sankyo Company, Limited
   14.4.1. Company Snapshot
   14.4.2. Overview
   14.4.3. Financial Overview
   14.4.4. Product Portfolio
   14.4.5. Key Developments
   14.4.6. Strategies
14.5. Emergent BioSolutions, Inc.
   14.5.1. Company Snapshot
   14.5.2. Overview
   14.5.3. Financial Overview
   14.5.4. Product Portfolio
   14.5.5. Key Developments
   14.5.6. Strategies
14.6. GlaxoSmithKline plc
   14.6.1. Company Snapshot
   14.6.2. Overview
   14.6.3. Financial Overview
   14.6.4. Product Portfolio
   14.6.5. Key Developments
   14.6.6. Strategies
14.7. Johnson & Johnson
   14.7.1. Company Snapshot
   14.7.2. Overview
   14.7.3. Financial Overview
   14.7.4. Product Portfolio
   14.7.5. Key Developments
   14.7.6. Strategies
14.8. MedImmune, LLC
   14.8.1. Company Snapshot
   14.8.2. Overview
   14.8.3. Financial Overview
   14.8.4. Product Portfolio
   14.8.5. Key Developments
   14.8.6. Strategies
14.9. Merck & Co., Inc.
   14.9.1. Company Snapshot
   14.9.2. Overview
   14.9.3. Financial Overview
   14.9.4. Product Portfolio
   14.9.5. Key Developments
   14.9.6. Strategies
14.10. Mitsubishi Tanabe Pharma Corporation
   14.10.1. Company Snapshot
   14.10.2. Overview
   14.10.3. Financial Overview
   14.10.4. Product Portfolio
   14.10.5. Key Developments
   14.10.6. Strategies
14.11. Others
   14.11.1. Company Snapshot
   14.11.2. Overview
   14.11.3. Financial Overview
   14.11.4. Product Portfolio
   14.11.5. Key Developments
   14.11.6. Strategies

CHAPTER 15. RESEARCH APPROACH
15.1. Research Methodology
   15.1.1. Initial Data Search
   15.1.2. Secondary Research
   15.1.3. Primary Research
15.2. Assumptions and Scope